Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.080
+0.010 (0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
2.070
-0.010 (-0.48%)
After-hours: Jun 26, 2026, 7:17 PM EDT
Compass Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Compass Therapeutics stock have an average target of 9.38, with a low estimate of 4.00 and a high estimate of 24. The average target predicts an increase of 350.96% from the current stock price of 2.08.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Compass Therapeutics stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 13 | 12 | 11 | 11 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $4 | Buy | Maintains | $12 → $4 | +92.31% | Jun 1, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $6 | Buy | Maintains | $6 | +188.46% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 → $24 | Buy | Reiterates | $10 → $24 | +1,053.85% | Jun 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $7 | Buy | Maintains | $7 | +236.54% | May 22, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 | Buy | Maintains | $6 | +188.46% | May 10, 2026 |
Financial Forecast
Revenue This Year
-2.22M
Revenue Next Year
25.67M
from -2.22M
EPS This Year
-0.44
from -0.42
EPS Next Year
-0.46
from -0.44
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 75.2M | |
| Avg | -2.2M | 25.7M | |
| Low | -28.8M | -6.3M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 1,140.6% |
| Avg | - | 394.2% |
| Low | - | -88.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.33 | -0.13 | |
| Avg | -0.44 | -0.46 | |
| Low | -0.59 | -0.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.